Case 15-2004: A 31-Year-Old Man with Bilateral Testicular Enlargement

New England Journal of Medicine

Volumn 350, Issue 20, 2004, Pages 2081-2087

  Ballen, Karen K ^a,b   Hasserjian, Robert P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEVER; HUMAN; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TESTIS BIOPSY; TESTIS CARCINOMA; TESTIS LYMPHOMA; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY; STEM CELL TRANSPLANTATION; TESTIS; TESTIS TUMOR;

ANTINEOPLASTIC AGENT;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, LYMPHOBLASTIC; MALE; RADIOTHERAPY; STEM CELL TRANSPLANTATION; TESTICULAR NEOPLASMS; TESTIS;

EID: 2342515441     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcpc049003     Document Type: Article

References (17)

1. Armstrong L, Jenkins S. It's not about the bike: my journey back to life. New York: Putnam, 2000.
2. Thrasher J, Frazier H. Non-germ cell testicular tumors. Prob Urol 1994;8:167-85.
3. Shahab N, Doll DC. Testicular lymphoma. Semin Oncol 1999;26:259-69.
4. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Vol. 3 of World Health Organization classification of tumours. Lyon, France: LARC Press, 2001.
5. Lin P, Jones D, Dorfman DM, Medeiros LJ. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol 2000;24:1480-90.
6. Ferry JA, Harris NL, Young RH, Coen J, Zietman A, Scully RE. Malignant lymphoma of the testis, epididymis, and spermatic cord: a clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 1994;18:376-90.
7. Zucca E, Conconi A, Mughal TI, et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol 2003;21:20-7.
8. Hoelzer D, Gokbuget N, Digel W, et al. Outcome of adult patients with T lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 2002;99:4379-85.
9. Kantarjian HM, O'Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000;18:547-661.
10. Larson RA, Dodge RK, Burns CP, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood 1995;85:2025-37.
11. Larson RA, Dodge RK, Linker CA, et al. A randomized trial of filgastrim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 1998;92:1556-64.
12. Tiedemann J, Chessells JM, Sandland RM. Isolated testicular relapse in boys with acute lymphoblastic leukaemia: treatment and outcome. Br Med J (Clin Res Ed) 1992;285:1614-6.
13. Dalle JH, Mechinaud F, Michon J, et al. Testicular disease in childhood B-cell non-Hodgkin's lymphoma: the French Society of Pediatric Oncology experience. J Clin Oncol 2001;19:2397-403.
14. Stirewalt DL, Guthrie KA, Beppu L, et al. Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation. Biol Blood Marrow Transplant 2003;9:206-12.
15. Levine JE, Harris RE, Loberiza FR Jr, et al. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood 2003;101:2476-82.
16. Lal A, Kwan E, al Mahr M, et al. Molecular detection of acute lymphoblastic leukaemia in boys with testicular relapse. Mol Pathol 1998;51:277-81.
17. Millot F, Suciu S, Philippe N, et al. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. J Clin Oncol 2001;19:1935-42.